Vitamin Shoppe, Inc. VSI Cash Flow

Vitamin shoppe, inc. (VSI)

CashFlow / Quarterly

Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Sep'18	Jun'18	Mar'18	Dec'17	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11
Cash flows from operating activities:
Net income (loss)
-3,409	-3,570	3,497	-5,327	-	-1,746	7,180	-3,859	-	-17,578	-86,150	-156,419	7,996	-11,614	11,363	10,433	14,782	6,132	14,098	14,241	18,700	11,609	12,197	16,926	20,509	11,219	16,268	18,262	20,797	9,678	16,291	16,595	18,261	9,412	11,911	11,952	11,589
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization of fixed assets, intangible assets and finance leases right-of-use assets
10,944	9,911	9,853	10,112	-	10,504	10,251	11,247	-	15,656	7,709	8,011	7,828	9,968	9,372	9,377	10,063	10,038	9,707	9,523	9,227	9,159	8,613	8,407	8,040	8,014	6,948	6,729	6,335	6,537	5,684	5,326	5,529	5,395	5,057	5,000	4,848
Impairment charges on intangible assets
0	9,000	0	0	-	0	0	8,174	-	0	59,405	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Impairment charges on fixed assets
204	790	0	1,466	-	718	131	8,742	-	786	287	5,585	0	382	197	0	218	856	0	321	0	-	-	-	-	-	-	-	-	0	202	0	528	-	-	-	-
Discontinued operations charge
-	-	0	-	-	-	-	1,450	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of Debt Issuance Costs
110	109	110	119	-	120	145	220	-	220	220	220	238	249	236	235	237	96	62	40	39	60	37	35	32	30	26	20	20	27	66	83	82	90	84	84	114
Contingent consideration for acquisition of FDC Vitamins, LLC
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	959	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain (Loss) on Extinguishment of Debt
0	0	0	673	-	0	3,727	12,502	-	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-552
Amortization of Debt Discount (Premium)
544	540	528	600	-	594	769	1,207	-	1,212	1,201	1,190	1,178	1,256	1,156	1,144	1,134	223	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on disposal of fixed assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-128	-23	-189	-371	-	-	-	-2
Deferred income taxes
-2,590	-1,511	1,225	-8,859	-	4,342	10,061	75	-	13,893	-22,502	-11,685	460	-14,992	-590	1,287	612	-4,612	904	2,110	234	-7,842	1,580	1,885	427	-49	55	362	177	-	-	-	-	-928	-1,345	640	157
Deferred rent
0	0	0	1,046	-	993	1,104	738	-	528	438	678	787	886	794	837	709	586	578	624	506	332	-47	77	141	29	-697	-69	-73	113	-167	-37	-201	-2,037	277	350	342
Non-cash portion of lease expense for operating leases
23,688	23,116	22,888	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Equity compensation expense
-110	315	632	923	-	809	56	875	-	1,985	1,427	1,110	1,600	1,586	1,172	1,824	1,710	775	1,230	1,343	2,143	1,140	1,966	1,883	1,912	1,504	2,468	2,511	1,850	1,808	1,791	1,561	1,340	1,374	1,389	1,382	1,021
Issuance of shares for services rendered
-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	166	167	167	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Tax benefits on exercises of equity awards
-26	-10	-402	-49	-	-38	-344	-361	-	-122	-148	-764	17	-25	-137	-460	-117	-438	-116	-68	113	-	-	-	1,625	1,264	98	408	304	24,463	-6,705	-4,236	-1,190	2,958	1,084	-1,897	-1,037
Changes in operating assets and liabilities:
Accounts receivable
0	0	0	0	-	487	-674	1,645	-	3,343	-36	-2,866	-1,543	409	1,577	-228	-1,828	2,372	-1,364	-837	-3,110	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Inventories
807	-9,946	1,681	873	-	-14,367	-10,695	-8,863	-	-8,814	11,093	-6,710	-6,142	17,584	-7,044	1,984	554	8,373	6,253	-2,645	26,303	-5,000	4,937	-2,939	5,460	-4,908	15,329	2,476	532	6,874	10,797	-9,592	8,122	11,177	-1,511	-3,651	4,174
Prepaid expenses and other current assets
-4,390	-1,111	1,018	-12,834	-	2,541	-2,219	821	-	-140	3,170	8,756	-5,870	4,114	-1,034	1,196	4,245	-4,675	2,686	-2,097	197	-14,660	8,007	11,359	-8,488	3,609	8,634	374	3,051	-5,001	2,964	-28	1,507	1,813	2,071	-1,242	1,617
Other long-term assets
-94	39	1,094	-19	-	-15	-17	67	-	648	-25	-15	-10	-10	-25	-74	-7	-82	4	-2	219	24	-9	-2,614	158	179	71	485	233	122	53	242	212	-42	-35	376	96
Accounts payable
3,034	2,043	-6,505	-3,110	-	-8,735	3,330	1,411	-	-12,629	8,822	1,985	-11,094	15,185	-5,542	4,437	12,442	-5,001	-856	-7,500	9,648	1,050	5,387	-12,426	-3,880	5,999	-3,084	4,284	4,489	-1,279	4,013	899	-1,407	1,349	3,875	-3,640	2,394
Accrued expenses and other current liabilities
-833	-4,862	-4,337	7,020	-	-5,501	8,545	-5,191	-	3,458	2,246	2,362	-1,019	12,363	-365	-14,200	5,123	3,481	6,163	533	-9,783	-421	14,110	5,445	-10,651	6,759	6,262	5,179	-19,616	7,528	14,611	1,339	-7,636	6,614	5,303	5,270	-3,546
Operating lease liabilities
-25,235	-24,260	-24,122	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other long-term liabilities
-240	-123	-112	-451	-	-232	-221	407	-	1,155	418	570	-49	-93	279	298	263	9	1,612	601	513	-4,434	2,622	1,682	1,525	-6,136	2,778	434	1,145	1,403	-1,793	247	639	361	-745	376	387
Net cash provided by operating activities
10,127	23,619	266	12,548	-	11,312	48,078	18,209	-	13,216	4,899	18,175	19,899	15,285	23,147	11,746	43,195	4,017	24,879	26,237	5,534	30,988	33,173	16,968	19,018	27,901	8,286	33,785	11,150	17,401	21,525	32,547	6,877	15,149	26,725	24,323	10,936
Cash flows from investing activities:
Capital expenditures
6,844	8,208	4,395	3,483	-	8,950	8,983	6,722	-	11,706	14,936	18,240	10,138	8,840	10,223	9,324	11,681	9,231	9,646	9,252	11,274	12,156	11,783	10,503	8,515	10,429	8,516	11,994	11,843	12,150	7,742	4,996	5,887	9,876	5,259	5,412	4,499
Acquisition of FDC Vitamins, LLC
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-487	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Acquisition of business
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	50,310	-	-	-	-	-	-	-	-
Trademarks and other intangible assets
156	178	135	122	-	87	73	90	-	115	157	74	82	70	50	80	91	70	137	158	149	116	166	228	179	262	124	166	96	-	-	-	-	-	-	-	-
Net cash used in investing activities
-7,000	-8,386	-4,530	-3,605	-	-9,919	6,673	-6,812	-	-11,821	-15,093	-18,314	-10,220	-8,910	-10,273	-9,404	-11,772	-9,301	-9,783	-9,410	-10,936	-12,272	-11,949	-92,269	-8,694	-10,691	-8,872	-11,838	-62,249	-12,549	-7,742	-4,996	-5,887	-9,876	-5,259	-5,412	-4,499
Cash flows from financing activities:
Borrowings under revolving credit facility
0	0	10,000	38,000	-	44,000	31,000	50,000	-	28,000	33,000	15,000	42,000	31,000	16,000	20,000	15,000	20,000	0	9,000	18,000	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	12,000
Repayments of borrowings under revolving credit facility
0	0	10,000	38,000	-	47,000	63,000	27,000	-	28,000	24,000	12,000	53,000	26,000	25,000	11,000	17,000	20,000	10,000	9,000	8,000	-	-	-	-	-	-	-	-	-	-	-	-	0	0	22,000	8,000
Purchases of convertible notes
0	0	0	6,733	-	0	23,118	34,040	-	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bank overdraft
-1,844	-2,106	3,564	-1,280	-	1,554	639	-312	-	-1,424	1,211	-2,099	-953	-664	1,286	-1,804	141	1,151	5,822	-4,538	4,538	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Payments of capital lease obligations
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	69	23	22	21	39	261	399	353	416	425	465	426
Contingent consideration payment for acquisition of FDC Vitamins, LLC
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	4,041	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Redemption of long term debt (Notes)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	55,106
Borrowings of long term debt - term loan
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	25,000
Proceeds from exercises of common stock options
-	-	-	-	-	-	-	-	-	-11	0	0	1,511	0	83	7	0	4	344	221	783	2,743	2,446	2,416	1,788	1,771	49	1,194	473	99	5,199	4,604	1,334	317	880	3,542	1,348
Issuance of shares under employee stock purchase plan
67	150	84	96	-	86	0	108	-	199	0	109	161	287	194	178	164	174	209	302	207	221	229	257	216	212	0	222	415	0	192	208	321	374	190	189	164
Purchases of treasury stock
19	5	287	29	-	31	59	185	-	15	21	537	7	30	201	759	215	38	212	2,179	101	95	90	2,136	94	-	-	-	-	-	-	-	-	-	-	-	-
Purchases of shares under Share Repurchase Programs
-	-	-	-	-	-	-	-	-	-	-	-	-	10,000	5,000	8,704	42,307	108,143	12,424	9,000	16,541	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Tax benefits on exercises of equity awards
-	-	-	-	-	-	-	-	-	-	-	-	-	-25	-137	-460	-117	-438	-116	-68	113	531	1,170	2,037	1,625	1,264	98	408	304	201	6,705	4,236	1,190	-742	-1,084	1,897	1,037
Deferred financing fees and other
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	85	0	5	485
Other financing activities
-126	-124	-123	356	-	-120	-102	-117	-	335	-115	-429	-137	111	-71	-34	-20	-	-36	-37	-24	-	-64	-63	-55	-	-	-	-	-	-	-	-	-	-	-	-
Net cash used in financing activities
-1,922	-2,085	3,238	-8,067	-	-1,511	-54,640	-11,546	-	-1,356	10,075	44	-10,425	-5,528	-12,846	-2,576	-44,354	18,350	-16,413	-15,299	-5,066	-38,744	-4,124	2,511	3,480	2,646	-13	1,659	1,171	261	11,835	8,649	2,492	-19,302	-3,564	-19,967	-24,468
Effect of exchange rate changes on cash and cash equivalents
0	0	0	-	-	0	0	1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net increase (decrease) in cash and cash equivalents
1,205	13,148	-1,026	-	-	-118	111	-148	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Effect of exchange rate changes on cash and cash equivalents
-	-	-	-	-	-	-	-	-	4	20	-1	12	-37	3	130	-77	57	-31	-53	156	33	35	-10	-14	-21	-36	17	-27	-	-	-	-	-	-	-	-
Net increase (decrease) in cash and cash equivalents
-	-	-	-	-	-	-	-	-	43	-99	-96	-734	810	31	-104	-13,008	13,123	-1,348	1,475	-10,312	-19,995	17,135	-72,800	13,790	19,835	-635	23,623	-49,955	5,114	25,618	36,200	3,482	-14,029	17,902	-1,056	-18,031
Supplemental disclosures of cash flow information:
Interest paid
-	805	88	967	276	-	1,362	581	-	1,843	176	1,660	274	1,836	141	1,673	65	158	102	115	65	74	39	78	58	121	90	91	88	90	91	90	91	267	207	601	1,326
Income taxes paid (refunded)
3	260	87	-4,186	-	35	-10,842	78	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income taxes paid
-	-	-	-	-	-	-	-	-	-	-	-	120	-	9,307	21,602	59	7,308	9,706	15,015	1,630	7,640	8,595	20,829	588	12,874	12,270	16,554	15,366	8,479	3,797	16,554	1,987	10,080	9,833	7,939	347
Supplemental disclosures of non-cash investing activities:
Liability for purchases of property and equipment
1,987	725	2,218	106	-	-4,159	1,894	4,094	-	-4,120	-1,440	-926	10,943	303	-1,447	1,192	4,582	1,880	303	665	4,649	-770	3,812	-693	6,030	1,164	845	-601	5,698	674	811	1,692	1,887	4,010	445	-724	1,260
Assets acquired under capital leases
-	-	-	-	-	-	-	-	-	0	0	0	891	0	1,589	0	0	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	264	-	-	-	-
Assets acquired under tenant incentives
-	-	-	-	-	-	-	-	-	0	0	0	2,986	0	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-